Dopamine agonist withdrawal syndrome: A comprehensive review
详细信息    查看全文
文摘
DAWS affects up to 19% of PD patients who undergo a dopamine agonist taper. ICD is a significant risk factor, not a requirement for development of DAWS. Recent data suggest that history of DBS may also be a risk factor for DAWS. Close surveillance for DAWS is crucial during dopamine agonist taper.
NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via email.